Genincode PLC (GENI.L) Diversifiers

Equity · Currency in GBp · Last updated Jun 6, 2026

GENinCode Plc develops and commercializes clinical genetic tests that provide predictive analysis of health risks based on patients' genes, offering preventative care and treatment strategies. Its in vitro diagnostic molecular tests combine clinical algorithms and bioinformatics to assess patient risk and predict disease onset across various conditions including cardiovascular diseases, familial hypercholesterolemia, hereditary thrombophilia, and ovarian cancer.

Looking to balance out your exposure to GENI.L? The ETFs below have the lowest correlation with GENI.L — they tend to move on their own, which can help reduce risk when GENI.L drops. The stock ideas table highlights individual companies that behave independently from GENI.L.

No Diversifiers Found for GENI.L

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements GENI.L

Add GENI.L to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with GENI.L